IE781231L - Dihydropyridine derivatives - Google Patents

Dihydropyridine derivatives

Info

Publication number
IE781231L
IE781231L IE781231A IE123178A IE781231L IE 781231 L IE781231 L IE 781231L IE 781231 A IE781231 A IE 781231A IE 123178 A IE123178 A IE 123178A IE 781231 L IE781231 L IE 781231L
Authority
IE
Ireland
Prior art keywords
carbon atoms
alkyl
alkoxy
hydrogen
independently
Prior art date
Application number
IE781231A
Other versions
IE47212B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE781231L publication Critical patent/IE781231L/en
Publication of IE47212B1 publication Critical patent/IE47212B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of formula I, <CHEM> wherein R1 is hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl or alkinyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, cycloalkylalkyl of 4 to 8 carbon atoms, phenylalkyl of 7 to 9 carbon atoms or phenylalkenyl of 9 to 12 carbon atoms, the phenyl ring being unsubstituted or monodi-, or trisubstituted independently by halogen, hydroxy or alkyl or alkoxy of 1 to 4 carbon atoms, R2 and R5, independently, are hydrogen or alkyl of 1 to 6 carbon atoms, R3 and R4, independently, are alkyl of 1 to 6 carbon atoms, alkenyl or alkinyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, cycloalkylalkyl of 4 to 8 carbon atoms, alkoxy of 1 to 6 carbon atoms, hydroxyalkoxy of 2 to 6 carbon atoms, alkoxyalkoxy of 3 to 6 carbon atoms, hydroxyalkoxyalkoxy of 4 to 8 carbon atoms, alkenyloxy or alkinyloxy of 3 to 6 carbon atoms, cycloalkyloxy of 3 to 7 carbon atoms or cycloalkylalkoxy of 4 to 8 carbon atoms, R6 is hydrogen, halogen, alkyl or alkoxy or alkylthio or alkylsulfonyl, each of 1 to 4 carbon atoms, trifluoromethyl, nitro or hydroxy, and is oxygen or sulphur are useful for treating coronary insufficiency and hypertension. [EP0000150A1]
IE1231/78A 1977-06-20 1978-06-19 Dihydropyridine derivatives,process for their production and pharmaceutical compositions containing them IE47212B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH752077 1977-06-20
CH286578 1978-03-16

Publications (2)

Publication Number Publication Date
IE781231L true IE781231L (en) 1978-12-20
IE47212B1 IE47212B1 (en) 1984-01-25

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1231/78A IE47212B1 (en) 1977-06-20 1978-06-19 Dihydropyridine derivatives,process for their production and pharmaceutical compositions containing them

Country Status (20)

Country Link
EP (1) EP0000150B1 (en)
JP (1) JPS54103876A (en)
AT (1) AT376220B (en)
AU (1) AU524000B2 (en)
CA (1) CA1105463A (en)
CY (1) CY1239A (en)
DE (1) DE2860708D1 (en)
DK (1) DK149855C (en)
ES (1) ES470917A1 (en)
FI (1) FI64938C (en)
HK (1) HK65184A (en)
IE (1) IE47212B1 (en)
IL (1) IL54948A (en)
IT (1) IT1105364B (en)
LU (1) LU88342I2 (en)
MY (1) MY8500041A (en)
NL (1) NL930126I2 (en)
NZ (1) NZ187617A (en)
PT (1) PT68191A (en)
SG (1) SG20584G (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI793848A (en) * 1978-12-18 1980-06-19 Sandoz Ag BENZOXADIAZOLER OCH BENZOTHIADIAZOLER DERAS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESSA
BE886259A (en) * 1979-11-23 1981-05-20 Sandoz Sa NOVEL DRUGS BASED ON 1,4-DIHYDROPYRIDINE DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DEFICIENCY OR WITH SPAMOLYTIC ACTION
CH655658B (en) * 1980-09-18 1986-05-15
FI813460L (en) * 1980-11-10 1982-05-11 Sandoz Ag NYA 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-PYRIDIN DERIVATIVES DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (en) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICINAL PRODUCTS
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
FR2528431B1 (en) * 1982-06-15 1986-01-10 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2554109A1 (en) * 1983-11-01 1985-05-03 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPEUTICS AS MEDICAMENTS
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
NL194389C (en) * 1984-06-14 2002-03-04 Novartis Ag Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier.
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
FI64938B (en) 1983-10-31
IL54948A0 (en) 1978-08-31
DE2860708D1 (en) 1981-08-27
NZ187617A (en) 1980-12-19
DK149855B (en) 1986-10-13
JPS54103876A (en) 1979-08-15
NL930126I2 (en) 1995-02-16
CA1105463A (en) 1981-07-21
SG20584G (en) 1985-03-08
FI64938C (en) 1984-02-10
PT68191A (en) 1978-07-01
EP0000150A1 (en) 1979-01-10
ES470917A1 (en) 1979-10-01
FI781867A (en) 1978-12-21
AT376220B (en) 1984-10-25
NL930126I1 (en) 1993-11-01
JPS6360755B2 (en) 1988-11-25
AU524000B2 (en) 1982-08-26
IT1105364B (en) 1985-10-28
CY1239A (en) 1984-06-29
IT7849939A0 (en) 1978-06-19
HK65184A (en) 1984-08-31
LU88342I2 (en) 1994-05-04
EP0000150B1 (en) 1981-05-20
ATA443178A (en) 1984-03-15
DK149855C (en) 1987-04-21
DK262578A (en) 1978-12-21
IE47212B1 (en) 1984-01-25
MY8500041A (en) 1985-12-31
AU3725278A (en) 1980-01-03
IL54948A (en) 1982-01-31

Similar Documents

Publication Publication Date Title
IE781231L (en) Dihydropyridine derivatives
ES8102107A1 (en) Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same.
AU4929690A (en) Phenyl pyradazine-3(2H)one, thiadizin-2(3H)one, triazin-3(2H) one and oxadiazin-5(4H)one derivatives for the treatment of congestive heart failure
MY101180A (en) Benzimidazole derivatives, and their production and use.
ES8802511A1 (en) 5-Amino-1-pyridyl-pyrazoles.
ES2003651A6 (en) Thiadiazabicyclononane derivatives, processes for their production and herbizidal compositions.
NO168246C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC COMPOUNDS.
ES2190809T3 (en) QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY.
KR880006238A (en) Susceptibility enhancers against multidrug-resistant cancer cells and methods for preparing the same
GR3003776T3 (en)
NO178188C (en) Analogous Process for Preparation of Therapeutically Active 4,5,6,7-Tetrahydro-benzimidazole Derivatives
DK628487D0 (en) CHEMICAL COMPOUNDS
ES8708136A1 (en) Barbituric-acid derivatives.
IE893211L (en) Benzoxazepinone Process
IE781382L (en) Indole derivatives
DE3174132D1 (en) New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof
EP0407621A4 (en) Benzothiazole derivatives
GB1533694A (en) Cyclopenta(b)furan-2-ol derivatives and processes for their preparation
GB1158632A (en) New Tri- and Tetrathiophosphate Esters
EP0372891A3 (en) Optically active compounds and a process for producing these compounds
ES8305751A1 (en) 1,2-Dithiol-3-ylidene ammonium derivatives, process for their preparation and medicines containing them.
ES8406489A1 (en) Pyrano-pyrazole derivatives.
ES8705363A1 (en) Tetrahydronaphthalenols for the treatment of hypertension.
IL78625A0 (en) Furanone derivatives and their preparation
PT87954A (en) METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING DIOXOPIPERIDINE DERIVATIVES WITH ANTI-PSYCHOSTIC EFFECT

Legal Events

Date Code Title Description
MK9A Patent expired